RaySearch Laboratories AB (publ) Market Cap ($650.46 Million)
Market Cap & Net Worth: RaySearch Laboratories AB (publ) (RAY-B)
RaySearch Laboratories AB (publ) market cap. RaySearch Laboratories AB (publ) (ST:RAY-B) has a market capitalization of $650.46 Million (Skr6.04 Billion) as of November 1, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #10550 globally and #177 in its home market, demonstrating a 4.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RaySearch Laboratories AB (publ)'s stock price Skr202.80 by its total outstanding shares 29803948 (29.80 Million). Also see cash flow conversion of RaySearch Laboratories AB (publ) for how efficiently the company converts equity into cash flow.
RaySearch Laboratories AB (publ) Market Cap History (2015–2026)
RaySearch Laboratories AB (publ) market cap history from 2015 to 2026. Data shows growth from $388.57 Million to $650.46 Million (6.44% CAGR). Check RaySearch Laboratories AB (publ) stock quote for real-time trading data and today's change.
RaySearch Laboratories AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RaySearch Laboratories AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of RaySearch Laboratories AB (publ) to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.54x
RaySearch Laboratories AB (publ)'s market cap is 0.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.21x
RaySearch Laboratories AB (publ)'s market cap is 3.21 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $586.49 Million | $531.47 Million | $151.41 Million | 1.10x | 3.87x |
| 2017 | $543.58 Million | $585.09 Million | $117.63 Million | 0.93x | 4.62x |
| 2018 | $306.76 Million | $627.22 Million | $78.52 Million | 0.49x | 3.91x |
| 2019 | $340.77 Million | $741.58 Million | $50.41 Million | 0.46x | 6.76x |
| 2020 | $262.89 Million | $651.61 Million | -$9.08 Million | 0.40x | N/A |
| 2021 | $179.60 Million | $641.67 Million | -$47.31 Million | 0.28x | N/A |
| 2022 | $216.16 Million | $843.65 Million | $23.78 Million | 0.26x | 9.09x |
| 2023 | $287.05 Million | $1.02 Billion | $81.57 Million | 0.28x | 3.52x |
| 2024 | $692.79 Million | $1.19 Billion | $203.51 Million | 0.58x | 3.40x |
| 2025 | $731.28 Million | $1.34 Billion | $227.80 Million | 0.54x | 3.21x |
Competitor Companies of RAY-B by Market Capitalization
Companies near RaySearch Laboratories AB (publ) in the global market cap rankings as of November 1, 2026. Also see RAY-B total assets for a full breakdown of the balance sheet.
Key companies related to RaySearch Laboratories AB (publ) by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of RaySearch Laboratories AB (publ) (2015–2026)
Market capitalization of RaySearch Laboratories AB (publ) from 2015 to today. Between 2015 and today, RaySearch Laboratories AB (publ)'s market cap moved from $388.57 Million to $ 650.46 Million, with a yearly change of 6.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr650.46 Million | -11.05% |
| 2025 | Skr731.28 Million | +5.56% |
| 2024 | Skr692.79 Million | +141.35% |
| 2023 | Skr287.05 Million | +32.79% |
| 2022 | Skr216.16 Million | +20.35% |
| 2021 | Skr179.60 Million | -31.68% |
| 2020 | Skr262.89 Million | -22.85% |
| 2019 | Skr340.77 Million | +11.09% |
| 2018 | Skr306.76 Million | -43.57% |
| 2017 | Skr543.58 Million | -7.32% |
| 2016 | Skr586.49 Million | +50.94% |
| 2015 | Skr388.57 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of RaySearch Laboratories AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $650.46 Million USD |
| MoneyControl | $650.46 Million USD |
| MarketWatch | $650.46 Million USD |
| marketcap.company | $650.46 Million USD |
| Reuters | $650.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more